Evidence map›Paper›PMID 37788448›Full record

ArticlePLoS medicine2023

Prioritizing persons deprived of liberty in global guidelines for tuberculosis preventive treatment.

Aditya Narayan, Argita D Salindri, Salmaan Keshavjee, Monde Muyoyeta, Kavindhran Velen, Zulma V Rueda, Julio Croda, Salome Charalambous, Alberto L García-Basteiro, Sheela V Shenoi and 12 more

Abstract read
In one paragraph

Article in PLoS medicine, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Lancet regional health. Americas · 2025
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

22 authors.

Aditya NarayanDivision of Infectious Diseases and Geographic Medicine, Stanford University School of Medicine, Stanford, California, United States of America.ORCID 0000-0002-2427-6445
Argita D SalindriDivision of Infectious Diseases and Geographic Medicine, Stanford University School of Medicine, Stanford, California, United States of America.ORCID 0000-0003-0962-0348
Salmaan KeshavjeeDepartment of Global Health and Social Medicine, Harvard Medical School, Boston, Massachusetts, United States of America.
Monde MuyoyetaCentre for Infectious Disease Research in Zambia (CIDRZ), Lusaka, Zambia.
Kavindhran VelenImplementation Division, The Aurum Institute, Johannesburg, South Africa.ORCID 0000-0001-8577-3915
Zulma V RuedaDepartment of Medical Microbiology and Infectious Diseases, University of Manitoba, Winnipeg, Canada.ORCID 0000-0001-6342-1812
Julio CrodaSchool of Medicine, Federal University of Mato Grosso do Sul, Campo Grande, Brazil.ORCID 0000-0002-6665-6825
Salome CharalambousImplementation Division, The Aurum Institute, Johannesburg, South Africa.
Alberto L García-BasteiroISGlobal, Hospital Clínic, Universitat de Barcelona, Barcelona, Spain.ORCID 0000-0002-2038-5505
Sheela V ShenoiDepartment of Medicine, Section of Infectious Diseases, Yale School of Medicine, New Haven, Connecticut, United States of America.ORCID 0000-0001-7654-4344
Crhistinne C M GonçalvesSchool of Medicine, Federal University of Mato Grosso do Sul, Campo Grande, Brazil.
Liliane Ferreira da SilvaSchool of Medicine, Federal University of Mato Grosso do Sul, Campo Grande, Brazil.
Lia G PossueloDepartment of Life Sciences, Santa Cruz do Sul University, Santa Cruz do Sul, Brazil.ORCID 0000-0002-6425-3678
Sarita AguirreNational Tuberculosis Control Program, Ministry of Public Health and Social Welfare (MSPyBS), Asunción, Paraguay.
Gladys EstigarribiaInstituto Regional de Investigación en Salud, Caaguazú, Paraguay.
Guillermo SequeraDepartment of Public Health, Facultad de Ciencias Médicas, Universidad Nacional de Asunción, Asunción, Paraguay.ORCID 0000-0002-7707-1363
Louis GrandjeanDepartment of Infection, Immunity and Inflammation, Institute of Child Health, University College London, London, United Kingdom.
Lily TelisingheLondon School of Hygiene and Tropical Medicine, London, United Kingdom.ORCID 0009-0003-3253-1906
Michael E HerceCentre for Infectious Disease Research in Zambia (CIDRZ), Lusaka, Zambia.ORCID 0000-0002-3629-3867
Fernanda DockhornMinistry of Health, Health and Environmental Surveillance Secretariat, General Coordination for Tuberculosis, Endemic Mycoses and Non-Tuberculous Mycobacteria Surveillance, Brasília, (DF) Brazil.ORCID 0000-0002-1762-9484
Frederick L AlticeDepartment of Medicine, Section of Infectious Diseases, Yale School of Medicine, New Haven, Connecticut, United States of America.
Jason R AndrewsDivision of Infectious Diseases and Geographic Medicine, Stanford University School of Medicine, Stanford, California, United States of America.ORCID 0000-0002-5967-251X

Funding

Yale Clinical and Translational Science Award (U Component)UL1TR001863 · NCATS · YALE UNIVERSITY · PI John H. Krystal, LUCILA OHNO-MACHADO · 2016 to 2026
$102.9M
NCATS NIH HHS UL1 TR001863
6 · The paper itself

Abstract

In this Policy Forum piece, Aditya Narayan and colleagues discuss the challenges and opportunities for tuberculosis preventive treatment in carceral settings.

Indexed as

TuberculosisFreedomHumansPolicy

Identifiers

PMID37788448
PMCPMC10547494

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.